Discovery of novel CSF biomarkers to predict progression in dementia using machine learning
Source check: Source checked. Not independent scientific confirmation.
Finding: The authors report group classification and candidate prioritization, while stating that no candidate is a strong individual predictor. The proteins are exploratory biomarkers; the source does not establish individual-level prognostic accuracy or clinical utility.
Technology: Random forests analyze cerebrospinal-fluid proteomics to classify fast versus slow dementia progression and prioritize TNFRSF4 and TGF-β1 candidates.
Publication: Preprint · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Random forests analyze cerebrospinal-fluid proteomics to classify fast versus slow dementia progression and prioritize TNFRSF4 and TGF-β1 candidates.
- Test and result
- The authors report group classification and candidate prioritization, while stating that no candidate is a strong individual predictor.
- Limitation / still unknown
- The proteins are exploratory biomarkers; the source does not establish individual-level prognostic accuracy or clinical utility.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.researchsquare.com/article/rs-2382373/v1
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.